An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
DOI:
https://doi.org/10.11606/s1518-8787.2022056004545Keywords:
Breast Neoplasms, prevention & control, Mammography, statistics & numerical data, Women’s Health, trends, COVID-19Abstract
We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of mammograms performed, in 2021; b) an exploratory analysis of the characteristics of the screened population between 2019 and 2021. A total of 1.675.307 mammograms were performed in 2021, nearly 15% lower than pre-pandemic levels. Almost a third, 29.5% of them, had intervals greater than three years. In accordance with our previous study, the number of patients with palpable lumps on physical exam increased. The consequences of postponing breast cancer screening during the pandemic are still uncertain. Unfortunately, as of December 2021, screening attendance has not resumed. On the contrary, our results show an increase in the fraction of women with mammography delayed beyond three years.
References
Bessa JF. Breast imaging hindered during covid-19 pandemic, in Brazil. Rev Saude Publica. 2021;55:8. https://doi.org/10.11606/s1518-8787.2021055003375
Molen DRM, Bargon CA, Batenburg MCT, Stam LE, Dam IE, Baas IO, et al. The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer. Breast Cancer Res Treat. 2022(191(3):553-64. https://doi.org/10.1007/s10549-021-06458-3
Tonneson JE, Hoskin TL, Day CN, Durgan DM, Dilaveri CA, Boughey JC. Impact of the COVID-19 pandemic on breast cancer stage at diagnosis, presentation, and patient management. Ann Surg Oncol. 2022;29:2231-9. https://doi.org/10.1245/s10434-021-11088-6
COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021;22(11):1507-17. https://doi.org/10.1016/S1470-2045(21)00493-9
Chiarelli AM, Walker MJ, Espino-Hernandez G, Gray N, Salleh A, Adhihetty C, et al. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study. CMAJ Open. 2021;9(4):E1205-12. https://doi.org/10.9778/cmajo.20200285
Canelo-Aybar C, Posso M, Montero N, Solà I, Saz-Parkinson Z, Duffy SW, et al. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). Br J Cancer. 2022;126(4):673-88. https://doi.org/10.1038/s41416-021-01521-8
Bretas G, Renna NL, Bines J. Practical considerations for expediting breast cancer treatment in Brazil. Lancet Reg Health Am. 2021;2:100028. https://doi.org/10.1016/j.lana.2021.100028
Published
Issue
Section
License
Copyright (c) 2022 Jordana de Faria Bessa, Guilherme Novita, Ruffo Freitas-Junior
This work is licensed under a Creative Commons Attribution 4.0 International License.
